Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Advances in the Study on the Relationship between Regulatory T cells and Human Papilloma Viral Infection

Advances in the Study on the Relationship between Regulatory T cells and Human Papilloma Viral... AbstractRegulatory T cells (Treg cells) are a group of negative regulatory cells that include non-specific immune regulation CD4+ T cells. Treg cells inhibit the function of other immune cells. CD4+ CD25+ FOXP3+ is a Treg cell that is co-expressed by CD25 and FOXP3. The expression of Treg cells is up-regulated in the focal microenvironment and peripheral blood of patients infected with human papilloma virus (HPV). Further studies on Treg cells indicate that their potential clinical applications in the treatment of HPV infection. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Infection International de Gruyter

Advances in the Study on the Relationship between Regulatory T cells and Human Papilloma Viral Infection

Infection International , Volume 5 (3): 6 – Sep 1, 2016

Loading next page...
 
/lp/de-gruyter/advances-in-the-study-on-the-relationship-between-regulatory-t-cells-o1lh0xLjrW

References (25)

Publisher
de Gruyter
Copyright
© 2016 Yuting Wang, published by De Gruyter Open
eISSN
2544-0349
DOI
10.1515/ii-2017-0136
Publisher site
See Article on Publisher Site

Abstract

AbstractRegulatory T cells (Treg cells) are a group of negative regulatory cells that include non-specific immune regulation CD4+ T cells. Treg cells inhibit the function of other immune cells. CD4+ CD25+ FOXP3+ is a Treg cell that is co-expressed by CD25 and FOXP3. The expression of Treg cells is up-regulated in the focal microenvironment and peripheral blood of patients infected with human papilloma virus (HPV). Further studies on Treg cells indicate that their potential clinical applications in the treatment of HPV infection.

Journal

Infection Internationalde Gruyter

Published: Sep 1, 2016

There are no references for this article.